Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00370331 · OUTCOME

Maximum and Total Weeks of Platelet Response

RAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With Eltrombopag · Source last updated 2017-04-18

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEDIAN
Unit
Weeks
Interval / dispersion
Full Range
Time frame
Day 1 through Week 26 on-treatment

What was measured

Response is defined as a platelet count between 50,000 and 400,000 platelets per microliter.

Analysis population: ITT Population

Groups in this outcome

Placebo

Matching placebo tablets taken once a day

Eltrombopag 50 mg QD

Eltrombopag 50 mg oral tablets taken once a day (QD)

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Placebo62
Eltrombopag 50 mg QD135

Reported measurements

Maximum continuous Response
Values in Weeks · Interval/dispersion: Full Range
GroupValueSpreadLowerUpperComment
Placebo0Not reported025Not reported
Eltrombopag 50 mg QD8.1Not reported026Not reported
Cumulative Response
Values in Weeks · Interval/dispersion: Full Range
GroupValueSpreadLowerUpperComment
Placebo0Not reported025Not reported
Eltrombopag 50 mg QD10.9Not reported026Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        0
        upper Limit
        25
        value
        0
      2. group Id
        OG001
        lower Limit
        0
        upper Limit
        26
        value
        8.1
    title
    Maximum continuous Response
  2. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        0
        upper Limit
        25
        value
        0
      2. group Id
        OG001
        lower Limit
        0
        upper Limit
        26
        value
        10.9
    title
    Cumulative Response
denoms
  1. counts
    1. group Id
      OG000
      value
      62
    2. group Id
      OG001
      value
      135
    units
    Participants
description
Response is defined as a platelet count between 50,000 and 400,000 platelets per microliter.
dispersion Type
Full Range
groups
  1. description
    Matching placebo tablets taken once a day
    id
    OG000
    title
    Placebo
  2. description
    Eltrombopag 50 mg oral tablets taken once a day (QD)
    id
    OG001
    title
    Eltrombopag 50 mg QD
param Type
MEDIAN
population Description
ITT Population
reporting Status
POSTED
time Frame
Day 1 through Week 26 on-treatment
title
Maximum and Total Weeks of Platelet Response
type
SECONDARY
unit Of Measure
Weeks

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice